Stable Angina
4
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
3
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
OrbusNeichChina - Hong Kong
2 programs2
COMBO-StentPhase 41 trial
Endothelial cell capture stent with 1 month clopidogrelPhase 41 trial
Active Trials
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
OrbusNeichCOMBO-Stent
OrbusNeichEndothelial cell capture stent with 1 month clopidogrel
Merck & Co.Nicorandil
Miracor MedicalPICSO
Clinical Trials (4)
Total enrollment: 1 patients across 4 trials
COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Start: Apr 2016Est. completion: Dec 20180
Phase 4Withdrawn
Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy
Start: Oct 2011Est. completion: Jan 20131 patients
Phase 4Terminated
Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
Start: Sep 2011Est. completion: May 2014
Phase 4Completed
Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention
Start: Oct 2010Est. completion: Apr 2011
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space